DBV Technologies expands scientific advisory board
This article was originally published in Scrip
Executive Summary
DBV Technologies (France), a biopharmaceutical company specialising in the development of non-invasive epicutaneous diagnostics and immunotherapies for allergies, has elected Professor Robert Zeiger to its scientific advisory board. Professor Zeiger is a clinical professor in the department of paediatrics at the UCSD School of Medicine and adjunct physician investigator for Kaiser Permanente Southern California.